Intervention effects of different brands of botulinum toxin type A on Meige syndrome with anxiety symptoms - Scorecard - MDSpire

Intervention effects of different brands of botulinum toxin type A on Meige syndrome with anxiety symptoms

  • By

  • Yunyu Tang

  • Ruen Liu

  • May 7, 2026

  • 0 min

Share

Clinical Scorecard: Comparative Analysis of Various Botulinum Toxin Type A Brands in Treating Meige Syndrome Accompanied by Anxiety Symptoms

At a Glance

CategoryDetail
Condition
Key MechanismsBotulinum toxin type A obstructs acetylcholine release at the neuromuscular junction, leading to muscle relaxation and reduced spasms.
Target Population
Care Setting

Key Highlights

  • No significant differences in efficacy between Hengli and Botox cohorts (p > 0.05).
  • Both treatments showed similar outcomes in anxiety and sleep metrics, but specify if these were statistically significant.

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

      • A
      • s
      • s
      • e
      • s
      • s
      • p
      • a
      • t
      • i
      • e
      • n
      • t
      • o
      • u
      • t
      • c
      • o
      • m
      • e
      • s
      • u
      • s
      • i
      • n
      • g
      • S
      • e
      • l
      • f
      • -
      • R
      • a
      • t
      • i
      • n
      • g
      • A
      • n
      • x
      • i
      • e
      • t
      • y
      • S
      • c
      • a
      • l
      • e
      • (
      • S
      • A
      • S
      • )
      • a
      • n
      • d
      • p
      • o
      • l
      • y
      • s
      • o
      • m
      • n
      • o
      • g
      • r
      • a
      • p
      • h
      • y
      • m
      • e
      • t
      • r
      • i
      • c
      • s
      • a
      • t
      • b
      • a
      • s
      • e
      • l
      • i
      • n
      • e
      • ,
      • 3
      • m
      • o
      • n
      • t
      • h
      • s
      • ,
      • a
      • n
      • d
      • 6
      • m
      • o
      • n
      • t
      • h
      • s
      • p
      • o
      • s
      • t
      • -
      • t
      • r
      • e
      • a
      • t
      • m
      • e
      • n
      • t
      • .

      Risks

        Patient & Prescribing Data

        148 individuals treated from January 2021 to December 2023.

        Both Hengli and Botox formulations showed comparable results in alleviating symptoms.

        Clinical Best Practices

        • Choose botulinum toxin type A brands based on pragmatic factors rather than efficacy differences.
        • Incorporate cognitive-behavioral therapy (CBT) and relaxation techniques alongside physical treatment.

        References

        Original Source(s)

        Intervention effects of different brands of botulinum toxin type A on Meige syndrome with anxiety symptoms

        • by Yunyu Tang, Ruen Liu

        • May 7, 2026

        Related Content

        IHS, ACP Differ on Migraine Tx

        Experts highlight differences between IHS and ACP recommendations as newer therapies reshape acute and preventive migraine care

        Can Lower Music Levels Preserve Workout Intensity?

        Despite preserved exertion perceptions, researchers report limited hearing protection use in group fitness classes.

        GLP-1 Drugs Linked to GI Effects, Uncertain Signals

        Umbrella review evaluates over 1,700 trials to assess noncardiometabolic outcomes beyond weight and glycemic effects.